Literature DB >> 11604304

Immune functions of the skin.

C Debenedictis1, S Joubeh, G Zhang, M Barria, R F Ghohestani.   

Abstract

Mesh：

Year:  2001        PMID： 11604304     DOI： 10.1016/s0738-081x(00)00173-5

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN： 0738-081X            Impact factor:   3.541


× No keyword cloud information.
  15 in total

1.  Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective antitumor immunity in mice.

Authors:  Tsuyoshi Itoh; Esteban Celis
Journal:  J Immunother       Date:  2005 Sep-Oct       Impact factor: 4.456

2.  Effect of tape stripping and adjuvants on immune response after intradermal DNA electroporation.

Authors:  Gaëlle Vandermeulen; Liévin Daugimont; Hervé Richiardi; Marie-Lise Vanderhaeghen; Nathalie Lecouturier; Bernard Ucakar; Véronique Préat
Journal:  Pharm Res       Date:  2009-04-21       Impact factor: 4.200

3.  Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.

Authors:  Min-Chul Kim; Jeong Woo Lee; Hyo-Jick Choi; Yu-Na Lee; Hye Suk Hwang; Jongsang Lee; Cheol Kim; Jong Seok Lee; Carlo Montemagno; Mark R Prausnitz; Sang-Moo Kang
Journal:  J Control Release       Date:  2015-05-21       Impact factor: 9.776

4.  Formulation of microneedles coated with influenza virus-like particle vaccine.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  AAPS PharmSciTech       Date:  2010-07-30       Impact factor: 3.246

5.  Enabling skin vaccination using new delivery technologies.

Authors:  Yeu-Chun Kim; Mark R Prausnitz
Journal:  Drug Deliv Transl Res       Date:  2011-02-01       Impact factor: 4.617

Review 6.  Targeting the skin for microneedle delivery of influenza vaccine.

Authors:  Dimitrios G Koutsonanos; Richard W Compans; Ioanna Skountzou
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

7.  Intradermal immunization improves protective efficacy of a novel TB vaccine candidate.

Authors:  Susan L Baldwin; Sylvie Bertholet; Maria Kahn; Irina Zharkikh; Gregory C Ireton; Thomas S Vedvick; Steven G Reed; Rhea N Coler
Journal:  Vaccine       Date:  2009-03-26       Impact factor: 3.641

8.  Transcutaneous vaccination via laser microporation.

Authors:  Richard Weiss; Michael Hessenberger; Sophie Kitzmüller; Doris Bach; Esther E Weinberger; Wolf D Krautgartner; Cornelia Hauser-Kronberger; Bernard Malissen; Christof Boehler; Yogeshvar N Kalia; Josef Thalhamer; Sandra Scheiblhofer
Journal:  J Control Release       Date:  2012-06-29       Impact factor: 9.776

9.  Cell recruitment and cytokines in skin mice sensitized with the vaccine adjuvants: saponin, incomplete Freund's adjuvant, and monophosphoryl lipid A.

Authors:  Juliana Vitoriano-Souza; Nádia das Dores Moreira; Andréa Teixeira-Carvalho; Cláudia Martins Carneiro; Fernando Augusto Mathias Siqueira; Paula Melo de Abreu Vieira; Rodolfo Cordeiro Giunchetti; Sandra Aparecida de Lima Moura; Ricardo Toshio Fujiwara; Maria Norma Melo; Alexandre Barbosa Reis
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

10.  The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter.

Authors:  Uzma A Hasan; Claudia Zannetti; Peggy Parroche; Nadège Goutagny; Marine Malfroy; Guillaume Roblot; Christine Carreira; Ishraq Hussain; Martin Müller; Joyce Taylor-Papadimitriou; Didier Picard; Bakary S Sylla; Giorgio Trinchieri; Ruslan Medzhitov; Massimo Tommasino
Journal:  J Exp Med       Date:  2013-06-10       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.